Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective

Herpes and HIV infection—has the time come to act?

Darren B. Russell

Cairns Sexual Health Centre, PO Box 902, Cairns, QLD 4870, Australia. Email:

Sexual Health 3(2) 67-71
Submitted: 5 January 2004  Accepted: 16 January 2006   Published: 26 May 2006


It has been known for some years that the ulcerative and inflammatory STIs lead to an increased risk of HIV transmission. In particular, there is a two- to four-fold increased risk of HIV-1 acquisition associated with prevalent herpes simplex virus type 2. The challenges are discussed herein.


[1]  Annan K . UNAIDS and World Health Organization Fact Sheet: Sub-Saharan Africa. UNAIDS Epidemic Update 2005. [verified May 2006].

[2]  National Centre in HIV Epidemiology and Clinical Research. 2005 Annual Surveillance Report. p. 5.

[3]  UNAIDS. [verified May 2006].

[4]  Fenton AF Imrie J 2005 Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why? Infect Dis Clin North Am 19 311 31 doi:10.1016/j.idc.2005.04.004 Pubmed Abstract

[5]  Swearingen SG Klausner JD 2005 Sildenafil use, sexual risk behaviour, and risk for sexually transmitted diseases, including HIV infection. Am J Med 118 6 571 77 doi:10.1016/j.amjmed.2005.01.042 Pubmed Abstract

[6]  O’Farrell N 2001 Targeted interventions required against genital ulcers in African countries worst affected by HIV infection. Bull World Health Organ 79 569 77 Pubmed Abstract

[7]  Wasserheit JN 1992 Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 19 61 7 Pubmed Abstract

[8]  Moss GB Overbaugh J Welch M Reilly M Bwayo J Plummer FA et al 1995 Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis 172 6 1469 74 Pubmed Abstract

[9]  Atkins MC Carlin EM Emery VC Griffiths PD Boag F 1996 Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 313 7053 341 2 Pubmed Abstract

[10]  Dickerson MC Johnston J Delea TE White A Andrews E 1996 The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 23 5 429 40 Pubmed Abstract

[11]  Uter W Pfahlberg A 2001 The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res 10 3 231 7 doi:10.1191/096228001680195175 Pubmed Abstract

[12]  Ghys PD Diallo MO Ettiegne-Traore V Satten GA Anoma CK Maurice C et al 2001 Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS 15 11 1421 31 doi:10.1097/00002030-200107270-00012 Pubmed Abstract

[13]  Grosskurth H Gray R Hayes R Mabey D Wawer M 2000 Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 355 9219 1981 7 doi:10.1016/S0140-6736(00)02336-9 Pubmed Abstract

[14]  Corey L Wald A Celum CL Quinn TC 2004 The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 35 5 435 45 Pubmed Abstract

[15]  Website for ‘’. [verified April 2006].

[16]  Fleming DT McQuillan GM Johnson RE Nahmias AJ Aral SO Lee FK et al 1997 Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337 1105 11 doi:10.1056/NEJM199710163371601 Pubmed Abstract

[17]  Chen CY Ballard RC Beck-Sague CM Dangor Y Radebe F Schmid S et al 2000 Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 27 21 9 Pubmed Abstract

[18]  Paz-Bailey G Rahman M Chen C Ballard R Moffat HJ Kenyon T et al 2005 Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin Infect Dis 41 9 1304 12 doi:10.1086/496979 Pubmed Abstract

[19]  Russell DB Tabrizi SN Russell JM Garland SM 2001 Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol 22 305 13 doi:10.1016/S1386-6532(01)00203-7 Pubmed Abstract

[20]  Auvert B Ballard R Campbell C Carael M Carton M Fehler G et al 2001 HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS 15 7 885 98 doi:10.1097/00002030-200105040-00009 Pubmed Abstract

[21]  Wald A Link K 2002 Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 185 45 52 doi:10.1086/338231 Pubmed Abstract

[22]  Renzi C Douglas JM Foster M Critchlow CW Ashley-Morrow R Buchbinder SP et al 2003 Herpes simplex type 2 infection as a risk factor for human immunodeficiency acquisition in men who have sex with men. J Infect Dis 187 19 25 doi:10.1086/345867 Pubmed Abstract

[23]  Freeman EE Glynn JR 2004 Factors affecting HIV concordancy in married couples in four African cities. AIDS 18 1715 21 doi:10.1097/01.aids.0000139075.13906.2f Pubmed Abstract

[24]  Auvert B Buvé A Ferry B Caraël M Morrison L Lagarde E et al 2001 Ecological and individual factor analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 15 Suppl 4 S15 30 doi:10.1097/00002030-200108004-00003 Pubmed Abstract

[25]  Blower S Ma L 2004 Calculating the contribution of Herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin Infect Dis 39 Suppl 5 S240 7 doi:10.1086/422361 Pubmed Abstract suppl 5

[26]  Corey L Tyring S Patel R Sacks SL Tyring SK Warren T et al 2004 Once daily valaciclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350 11 20 doi:10.1056/NEJMoa035144 Pubmed Abstract

[27]  World Health Organization. Microbicides. [verified April 2006].

[28]  Dhawan D Mayer KH 2006 Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection. J Infect Dis 193 1 36 44 doi:10.1086/499163 Pubmed Abstract

[29]  Diamond C Richardson JL Milam J Stoyanoff S McCutchan JA Kemper C et al 2005 Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J Acquir Immune Defic Syndr 39 2 211 8 Pubmed Abstract

[30]  Bateganya M Colfax G Shafer LA Kityo C Mugyenyi P Serwadda D et al 2005 Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDS 19 11 760 8 doi:10.1089/apc.2005.19.760 Pubmed Abstract

[31]  Bunnell R Ekwaru JP Solberg P Wamai N Bikaako-Kajura W Were W et al 2006 Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 20 1 85 92 doi:10.1097/01.aids.0000196566.40702.28 Pubmed Abstract

[32]  Smith RJ Bodine EN Wilson DP Blower SM 2005 Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS 19 4 413 21 doi:10.1097/01.aids.0000161771.44276.92 Pubmed Abstract

[33]  Auvert B , Puren A , Taljaard D , Lagarde E , Sitta R , Tambekou J , et al Impact of male circumcision on the female-to-male transmission of HIV. Program and abstracts of the 3rd IAS Conference on HIV Pathogenesis and Treatment, 24–27 July 2005, Rio de Janeiro, Brazil. Abstract TuOa0402.

Export Citation